New Deal
Announced
Completed
Share
Financials
Show More
Stada Arzneimittel
Bain Capital
Cinven
Sources
Tags
generic drugmaker
Pharmaceuticals
Germany
Public
Acquisition
Friendly
Private Equity
Majority
Synopsis
Bain Capital, private equity firm, and Cinven, private equity firm, acquired 63% of the outstanding shares of the German generic drugmaker STADA Arzneimittel.
Service Providers (27)
Dealmakers
Perella Weinberg Partners
Evercore
Freshfields Bruckhaus Deringer
Skadden Arps Slate Meagher & Flom
Deutsche Bank
Jp Morgan
Macquarie Group
Ubs
Barclays
Rothschild & Co
Societe Generale
Jefferies & Company
Nomura
Camarco
Kirkland & Ellis
Linklaters
Latham & Watkins
Fti Consulting
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.